Physician profile
Samir Belagaje
NPI 1316158603
$1,748.27
in general payments reported to CMS, 2019-2025
7 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $10.00 · 2021: $46.27 · 2022: $69.99 · 2023: $1,432 · 2024: $190.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $997 · Food and Beverage: $625.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $996.62 |
| Food and Beverage | $625.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Livanova USA, INC. | $1,381.15 | 2023 | Vns Therapy |
| Microtransponder, INC. | $190.30 | 2024 | |
| Abbvie INC. | $73.81 | 2022-2023 | Botox |
| W. L. Gore & Associates, INC. | $46.27 | 2021 | |
| Grt US Holding, INC. | $25.43 | 2022 | |
| Allergan, INC. | $21.31 | 2022 | |
| Penumbra, INC. | $10.00 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Samir Belagaje listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.